Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Silexion Therapeutics Corp is an Israel-based oncology-focused biotechnology company. The Company is engaged in development of treatments for unsatisfactorily treated solid tumor cancers, which have the mutated KRAS oncogene. The KRAS gene is an oncogene that is involved in regulation of cell division as a result of its ability to relay external signals to the cell nucleus. Based on its research of refractory solid tumor cancers, it is developing a platform focused on the silencing of the KRAS oncogene using ribonucleic acid (RNA)-interference therapeutics. Its lead product candidate, SIL-204B, consists of locally administered small interfering RNAs (siRNA), in an extended-release formulation, as a preferred treatment of locally advanced pancreatic cancer patients, in combination with standard-of-care chemotherapy. Its clinical-stage pipeline is focused on treatment for pancreatic cancer (PC) tumors bearing the KRAS G12D or KRAS G12V mutations where metastases have not been detected.
Find out what a historical investment in Silexion Therapeutics Corp would be worth today using our SLXN stock calculator.
Buying SLXN shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Silexion Therapeutics Corp in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in SLXN
What is the ticker symbol of Silexion Therapeutics Corp?
The ticker symbol for Silexion Therapeutics Corp is SLXN.
How much is one share of SLXN?
One share of SLXN is valued at $1.50 as of 20 November 2026.
What is the market capitalisation of Silexion Therapeutics Corp SLXN?
As of 20 November 2026 Silexion Therapeutics Corp has a market cap of $935.32K.
What is the 52-week high for Silexion Therapeutics Corp stock?
The Silexion Therapeutics Corp 52-week high stock price is $777.12.
What is the 52-week low for Silexion Therapeutics Corp stock?
The Silexion Therapeutics Corp 52-week low stock price is $1.26.
Can I buy SLXN shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy SLXN shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in SLXN on Stake
Buy SLXN from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of SLXN from only US$10 with fractional shares